Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma

Improved therapies for individuals with head and neck squamous cell carcinoma (HNSCC) may be developed by identification of appropriate biomarkers. The aim of this study was to evaluate the usefulness of serum midkine measurement as a biomarker for HNSCC. Pretreatment serum midkine concentrations we...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Med
Prif Awduron: Yamashita, Taku, Shimada, Hideaki, Tanaka, Shingo, Araki, Koji, Tomifuji, Masayuki, Mizokami, Daisuke, Tanaka, Nobuaki, Kamide, Daisuke, Miyagawa, Yoshihiro, Suzuki, Hiroshi, Tanaka, Yuya, Shiotani, Akihiro
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2016
Pynciau:
Clinical Cancer Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4799940/
https://ncbi.nlm.nih.gov/pubmed/26798989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.600
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg